NCT05326282View on ClinicalTrials.gov

Evaluating the Role of Ultrasound in Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

November 1, 2023

Study Completion Date

February 27, 2024

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Multi-parametric ultrasound

Diagnostic ultrasound parameters used to evaluate the prostate. Transrectal scans will be performed

Trial Locations (1)

HU16 5JZ

Ultrasound, Radiology, Hull

All Listed Sponsors
collaborator

University of Hull

OTHER

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT05326282 - Evaluating the Role of Ultrasound in Prostate Cancer | Biotech Hunter | Biotech Hunter